Replimune Group, Inc.

NASDAQ:REPL

Biotechnology

Healthcare
$19.81 +1.85%

+$0.19 today

Market cap
$1.88B
Beta
0.91
P/E (TTM)
-3.0
EPS (TTM)
-$3.42
52W Low $1.50High $13.24

Volume 2.13M

Average 7.51M

Balance Sheet

Inspect the capital base behind the business.

Assets

$551.33M

FY 2025 · Annual

+13.0% YoY

Liabilities

$135.49M

FY 2025 · Annual

+19.7% YoY

Equity

$415.84M

FY 2025 · Annual

+11.0% YoY

Balance Sheet

USD
Metric
FY2021
Mar 2021
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
Cash & Equivalents182.52M105.95M146.59M74.46M111.12M
Short-term Investments293.78M289.71M436.8M346.21M372.69M
Net Receivables2.95M3.06M2.94M4.92M3.73M
Inventory00000
Other Current Assets006.28M8.08M0
Total Current Assets483.75M403.98M592.6M433.67M495.88M
Property, Plant & Equipment (Net)57.72M55.58M52.35M52.36M52.55M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets1.64M1.64M1.64M1.7M2.9M
Total Non-current Assets59.35M57.22M53.99M54.06M55.45M
Total Assets543.1M461.19M646.59M487.72M551.33M
Account Payables2.36M3.73M5.36M2.58M12.46M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities4.47M6.89M12.9M17.24M6.07M
Total Current Liabilities14.55M20.76M33.83M40.44M62.36M
Long-term Debt0028.65M44.81M46.38M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00472K786K941K
Total Non-current Liabilities29.82M29.21M57.47M72.78M73.12M
Total Liabilities44.37M49.96M91.3M113.21M135.49M
Common Stock47K47K57K61K77K
Retained Earnings(193.17M)(311.2M)(485.49M)(701.28M)(948.58M)
Accumulated OCI(394K)(973K)5.73M4.86M5.45M
Other Stockholders Equity00000
Minority Interest00000
Total Equity498.73M411.23M555.29M374.51M415.84M
Total Debt33.28M32.84M60.76M75.87M76.17M
Net Debt(149.24M)(73.11M)(85.83M)1.41M(34.95M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$123.0M
Short-term Investments$146.2M
Receivables$3.0M
Other Current$8.3M
Total Current Assets$280.4M
PP&E (Net)$50.3M
Long-term Investments$1.7M
Other Non-current$1.2M
Total Non-current Assets$53.2M
Total Assets$333.6M

Analysis

Selected assets total $333.6M for Latest. The largest visible component is Short-term Investments at $146.2M, about 43.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 10, 2026
4Statement of changes in beneficial ownershipNov 10, 2026
SC 13G/ASC 13G/A filingNov 9, 2026
10-Q/A10-Q/A filingNov 6, 2026
4Statement of changes in beneficial ownershipNov 3, 2026

How much cash does REPL have?

Replimune Group, Inc. (REPL) reported $111.12M in cash and equivalents in fiscal 2025.

How much debt does REPL carry?

Replimune Group, Inc. (REPL) reported $76.17M of total debt, with net debt of -$34.95M.